Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
8.49
-0.28 (-3.19%)
At close: Mar 9, 2026, 4:00 PM EDT
8.65
+0.16 (1.88%)
After-hours: Mar 9, 2026, 6:57 PM EDT
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $155.74 million as of March 9, 2026. Its market cap has increased by 102.26% in one year.
Market Cap
155.74M
Enterprise Value
398.31M
1-Year Change
102.26%
Ranking
Category
Stock Price
$8.49
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $155.74M, a decrease of -64.84%. That is a compound annual growth rate of -8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 160.90M | 28.21% |
| Dec 31, 2025 | 125.50M | 48.17% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 175.94M |
| Tonix Pharmaceuticals Holding | 172.08M |
| Caribou Biosciences | 170.11M |
| Jyong Biotech | 166.10M |
| Milestone Pharmaceuticals | 160.50M |
| Immunic | 160.47M |
| Rani Therapeutics Holdings | 157.98M |
| Fate Therapeutics | 154.63M |